DrugPatentWatch Database Preview
Amphastar Pharm Company Profile
Email this page to a colleague
What is the competitive landscape for AMPHASTAR PHARM, and what generic and branded alternatives to AMPHASTAR PHARM drugs are available?
AMPHASTAR PHARM has twelve approved drugs.
Summary for Amphastar Pharm
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 12 |
| Patent Litigation for Amphastar Pharm: | See patent lawsuits for Amphastar Pharm |
Drugs and US Patents for Amphastar Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharm | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 076684-005 | Sep 19, 2011 | AP | RX | No | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | ||||
| Amphastar Pharms Inc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 209832-001 | Dec 18, 2017 | DISCN | No | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | |||||
| Amphastar Pharm | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 076684-007 | Sep 19, 2011 | AP | RX | No | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | ||||
| Amphastar Pharms Inc | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 209933-002 | Sep 25, 2017 | AP | RX | No | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
